MARY ELLIOTT: Open Payments
NPI 1710594403 · GUILFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$38,043 in 140 payments from 14 companies in 2025. Trend: 2023 $2,095 · 2024 $2,261 · 2025 $38,043
Speaker / faculty: $22,865Travel & lodging: $10,217Food & beverage: $3,403Consulting: $1,360Education: $198
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 47 | $35,614 |
| ABBVIE INC. | 39 | $1,106 |
| Amgen Inc. | 12 | $305 |
| UCB, Inc. | 13 | $275 |
| E.R. Squibb & Sons, L.L.C. | 9 | $241 |
| GENZYME CORPORATION | 4 | $137 |
| AstraZeneca Pharmaceuticals LP | 4 | $99 |
| Lilly USA, LLC | 3 | $89 |
| GlaxoSmithKline, LLC. | 3 | $60 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
Products named: TREMFYA, RINVOQ, SKYRIZI, Bimzelx, ORENCIA, ENBREL, KEVZARA, SAPHNELO.
Industry payments across CT — which companies pay providers there.
